Duke, UNC-Chapel Hill scientists identify new antibody for COVID-19 and variants
November 2, 2021 A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.
Cellular quality-control system identified as a culprit in coronavirus infection
November 1, 2021 MERS, caused by a coronavirus strain of the same name, holds clues for respiratory diseases like COVID-19.
NC prisons study finds better, safer outcomes with diversion program for mental, behavioral health
October 29, 2021 Researchers found that people experiencing incarceration in North Carolina who were assigned to a therapeutic diversion unit instead of restrictive housing were at least three times less likely to commit further infractions, harm themselves or require inpatient mental health treatment.
Multiple-drug involvement in overdose deaths has risen in NC
October 14, 2021 Between 2015 and 2019, North Carolina saw an increase in overdose deaths that involved multiple drugs, highlighting the rapidly changing nature of drug overdoses in the state.
Carolina research produces effective experimental pill to treat COVID-19
October 1, 2021 University of North Carolina at Chapel Hill research set the stage to seek emergency authorization of the first oral antiviral drug to treat COVID-19.
New study gives insight into how often COVID-19 spreads through households
August 30, 2021 The study reports on how frequently COVID-19 spreads to other people living in the same household as someone diagnosed with the illness. The researchers emphasize that having many people living in one household is a major factor in infection risk, which disproportionately affects communities of color.
Two Gillings leaders advance research on innovative solutions to public health challenges
August 24, 2021 Drs. Mark Sobsey and Steven Meshnick were two early recipients of Gillings Innovation Lab awards that proposed public health improvements to global communities and provided instrumental mentorship to students and faculty at UNC and the Gillings School today.
Mother-infant hepatitis B treatment, prevention feasible in sub-Saharan Africa
August 20, 2021 A study in Lancet Global Health, co-authored by a UNC Gillings student, shows the feasibility and acceptance of hepatitis B virus testing, treatment and vaccination programs in the Democratic Republic of the Congo.
Carolina to lead $15 million statewide COVID-19 surveillance program funded by NC Policy Collaboratory
July 26, 2021 A new surveillance program, led by UNC-Chapel Hill's Dirk Dittmer, Amir Barzin and Audrey Pettifor, will collect, sequence and share data on SARS-CoV-2 samples from across the state, providing real-time information on variants circulating in North Carolina.
Study testing how well COVID-19 vaccine prevents spread of SARS-CoV-2 among university students expands to include young adults not in college
July 6, 2021 The Prevent COVID U study, which launched in late March 2021 to evaluate SARS-CoV-2 infection and transmission among university students vaccinated with the Moderna COVID-19 Vaccine, has expanded beyond the college setting. The study is now enrolling young adults ages 18 through 29 years — both those who want to be vaccinated and those who choose not to receive a vaccine.
